2013Zhongguo yaofangRequires access

Study on Bioequivalence of Ambroxol Hydrochloride Oral Disintegrating Tablets in Healthy Volunteers

Chang Shik Hong

Open publisher page 0 citations

Abstract

OBJECTIVE:To study the bioequivalence of Ambroxol hydrochloride oral disintegrating tablets in healthy volunteers after significant change of manufacturing technology.METHODS:Test preparation and reference preparation each 30 mg were given to 20 male healthy volunteers in randomized two-way crossover design.Blood samples were collected within 48 h after medication using pramipexole as internal standard.Plasma concentrations of ambroxol hydrochloride were determined by LC-MS,and pharmacokinetic parameters were analyzed using DAS 2.0 software.RESULTS:The pharmacokinetics parameters of test preparation and reference preparation were as follows:cmax(84.96±32.46)ng/ml and(90.86±44.81) ng/ml;tmax(1.7±0.7) h and(1.4±0.3) h;AUC0-48 h(678.85±235.17) ng·h/ml and(663.87±214.37)ng·h/ml;t1/2(9.8±1.9) h and(9.7±2.0)h,respectively.There was no significant difference in main pharmacokinetic parameters of them.CONCLUSIONS:Two preparations are bioequivalent after significant change of manufacturing technology.

About this research paper

What this paper is about

OBJECTIVE:To study the bioequivalence of Ambroxol hydrochloride oral disintegrating tablets in healthy volunteers after significant change of manufacturing technology.METHODS:Test preparation and reference preparation each 30 mg were given to 20 male healthy volunteers in randomized two-way crossover design.Blood samples were collected within 48 h after medication using pramipexole as internal standard.Plasma concentrations of ambroxol hydrochloride were determined by LC-MS,and pharmacokinetic parameters were analyzed using DAS 2.0 software.RESULTS:The pharmacokinetics parameters of test preparation and reference preparation were as follows:cmax(84.96±32.46)ng/ml and(90.86±44.81) ng/ml;tmax(1.7±0.7) h and(1.4±0.3) h;AUC0-48 h(678.85±235.17) ng·h/ml and(663.87±214.37)ng·h/ml;t1/2(9.8±1.9) h and(9.7±2.0)h,respectively.There was no significant difference in main pharmacokinetic parameters of them.CONCLUSIONS:Two preparations are bioequivalent after significant change of manufacturing technology.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

OBJECTIVE:To study the bioequivalence of Ambroxol hydrochloride oral disintegrating tablets in healthy volunteers after significant change of manufacturing technology.METHODS:Test preparation and reference preparation each 30 mg were given to 20 male healthy volunteers in randomized two-way crossover design.Blood samples were collected within 48 h after medication using pramipexole as internal standard.Plasma concentrations of ambroxol hydrochloride were determined by LC-MS,and pharmacokinetic parameters were analyzed using DAS 2.0 software.RESULTS:The pharmacokinetics parameters of test preparation and reference preparation were as follows:cmax(84.96±32.46)ng/ml and(90.86±44.81) ng/ml;tmax(1.7±0.7) h and(1.4±0.3) h;AUC0-48 h(678.85±235.17) ng·h/ml and(663.87±214.37)ng·h/ml;t1/2(9.8±1.9) h and(9.7±2.0)h,respectively.There was no significant difference in main pharmacokinetic parameters of them.CONCLUSIONS:Two preparations are bioequivalent after significant change of manufacturing technology.

Key concepts: Bioequivalence, Cmax, Pharmacokinetics, Ambroxol, Crossover study, Pharmacology, Hydrochloride, Chromatography

Related papers

Back to paper searchBrowse research topicsOriginal source
Study on Bioequivalence of Ambroxol Hydrochloride Oral Disintegrating Tablets in Healthy Volunteers — Research Paper | ScholarLens